Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
Showing news related to
Final analysis shows durable outcomes in MF and SS
Original title: “MINT study results strengthen real‑world evidence for mogamulizumab”
sustained response orr4 as an on treatment prognostic marker in mogamulizumab treated mycosis fungoides and s zary syndrome the fil moga study
Original title: “Sustained response (ORR4) as an on-treatment prognostic marker in mogamulizumab-treated mycosis fungoides and Sézary syndrome: the FIL-MOGA study.”
oral mycosis fungoides
Original title: “Oral mycosis fungoides.”
psychological distress symptom burden and quality of life in patients with mycosis fungoides and s zary syndrome
Original title: “Psychological Distress, Symptom Burden and Quality of Life in Patients with Mycosis Fungoides and Sézary Syndrome.”
prognostic value of skin lesion characteristics in subcutaneous panniculitis like t cell lymphoma a retrospective cohort study assessing the applicability of t category of the tnm classification for primary cutaneous lymphomas other than mycosis fungoides and s zary syndrome
Original title: “Prognostic Value of Skin Lesion Characteristics in Subcutaneous Panniculitis-Like T-Cell Lymphoma: A Retrospective Cohort Study Assessing the Applicability of T Category of the TNM Classification for Primary Cutaneous Lymphomas Other Than Mycosis Fungoides and Sézary Syndrome.”
hypopigmented mycosis fungoides with childhood onset and middle aged onset two case reports focusing on the cutaneous immune microenvironment
Original title: “Hypopigmented Mycosis Fungoides With Childhood-Onset and Middle-Aged Onset: Two Case Reports Focusing on the Cutaneous Immune Microenvironment.”
mycosis fungoides following il 17 inhibitor treatment a case series of five patients
Original title: “Mycosis Fungoides Following IL-17 Inhibitor Treatment: A Case Series of Five Patients.”
real world outcomes of mycosis fungoides and site specific nodal involvement a registry based study of 25 467 patients
Original title: “Real-World Outcomes of Mycosis Fungoides and Site-Specific Nodal Involvement: A Registry-Based Study of 25 467 Patients.”
mycosis fungoides with large cell lymphoma transformation a report of a rare case
Original title: “Mycosis Fungoides With Large Cell Lymphoma Transformation: A Report of a Rare Case.”
diagnostic delay in mycosis fungoides insights from china s first multicentre registry of 305 patients
Original title: “Diagnostic delay in mycosis fungoides: Insights from China's first multicentre registry of 305 patients.”
single cell proteomics reveal lesion specific aberrant t cells and immunological profiles in mycosis fungoides
Original title: “Single-cell proteomics reveal lesion-specific aberrant T cells and immunological profiles in Mycosis Fungoides.”
management of mycosis fungoides with chlormethine hydrochloride gel in combination with systemic therapies a case series
Original title: “Management of Mycosis Fungoides With Chlormethine Hydrochloride Gel in Combination With Systemic Therapies: A Case Series.”
resminostat for maintenance treatment in patients with advanced stage mycosis fungoides or s zary syndrome a multicentre double blind randomised placebo controlled phase 2 trial
Original title: “Resminostat for maintenance treatment in patients with advanced-stage mycosis fungoides or Sézary syndrome: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.”